diclofenac epolamine 1.3 % Once-Daily Medicated Patch

RxCUI
2385117
RxNorm name
diclofenac epolamine 1.3 % Once-Daily Medicated Patch
Display name
diclofenac epolamine 1.3 % Once-Daily Medicated Patch
Full name
diclofenac epolamine 1.3 % Once-Daily Medicated Patch
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:07

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
LICARTDICLOFENAC EPOLAMINEIBSA Pharma Inc.851c8b39-6056-4bbc-812e-b9b13977c1ac2026-04-02Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2385117

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
851c8b39-6056-4bbc-812e-b9b13977c1acdiclofenac epolamine 1.3 % Once-Daily Medicated PatchSY15These highlights do not include all the information needed to use LICART ® safely and effectively. See full prescribing information for LICART. LICART ® (diclofenac epolamine) topical system Initial U.S. Approval: 198820260402
851c8b39-6056-4bbc-812e-b9b13977c1acOnce-Daily diclofenac epolamine 0.013 MG/MG Medicated PatchSCD15These highlights do not include all the information needed to use LICART ® safely and effectively. See full prescribing information for LICART. LICART ® (diclofenac epolamine) topical system Initial U.S. Approval: 198820260402
851c8b39-6056-4bbc-812e-b9b13977c1acdiclofenac epolamine 1.3 % Once-Daily Medicated PatchPSN15These highlights do not include all the information needed to use LICART ® safely and effectively. See full prescribing information for LICART. LICART ® (diclofenac epolamine) topical system Initial U.S. Approval: 198820260402